Cargando…
VEGF Regulation of Angiogenic Factors via Inflammatory Signaling in Myeloproliferative Neoplasms
Background: Chronic inflammation has been recognized in neoplastic disorders, including myeloproliferative neoplasm (MPN), as an important regulator of angiogenesis. Aims: We investigated the influence of vascular endothelial growth factor (VEGF) and pro-inflammatory interleukin-6 (IL-6) on the expr...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268588/ https://www.ncbi.nlm.nih.gov/pubmed/34206393 http://dx.doi.org/10.3390/ijms22136671 |
_version_ | 1783720390242074624 |
---|---|
author | Subotički, Tijana Mitrović Ajtić, Olivera Živković, Emilija Diklić, Miloš Đikić, Dragoslava Tošić, Milica Beleslin-Čokić, Bojana Dragojević, Teodora Gotić, Mirjana Santibanez, Juan F. Čokić, Vladan |
author_facet | Subotički, Tijana Mitrović Ajtić, Olivera Živković, Emilija Diklić, Miloš Đikić, Dragoslava Tošić, Milica Beleslin-Čokić, Bojana Dragojević, Teodora Gotić, Mirjana Santibanez, Juan F. Čokić, Vladan |
author_sort | Subotički, Tijana |
collection | PubMed |
description | Background: Chronic inflammation has been recognized in neoplastic disorders, including myeloproliferative neoplasm (MPN), as an important regulator of angiogenesis. Aims: We investigated the influence of vascular endothelial growth factor (VEGF) and pro-inflammatory interleukin-6 (IL-6) on the expression of angiogenic factors, as well as inflammation-related signaling in mononuclear cells (MNC) of patients with MPN and JAK2V617F positive human erythroleukemic (HEL) cells. Results: We found that IL-6 did not change the expression of angiogenic factors in the MNC of patients with MPN and HEL cells. However, IL-6 and the JAK1/2 inhibitor Ruxolitinib significantly increased angiogenic factors—endothelial nitric oxide synthase (eNOS), VEGF, and hypoxia-inducible factor-1 alpha (HIF-1α)—in patients with polycythemia vera (PV). Furthermore, VEGF significantly increased the expression of HIF-1α and eNOS genes, the latter inversely regulated by PI3K and mTOR signaling in the MNC of primary myelofibrosis (PMF). VEGF and inhibitors of inflammatory JAK1/2, PI3K, and mTOR signaling reduced the eNOS protein expression in HEL cells. VEGF also decreased the expression of eNOS and HIF-1α proteins in the MNC of PMF. In contrast, VEGF increased eNOS and HIF-1α protein expression in the MNC of patients with PV, which was mediated by the inflammatory signaling. VEGF increased the level of IL-6 immunopositive MNC of MPN. In summary, VEGF conversely regulated gene and protein expression of angiogenic factors in the MNC of PMF, while VEGF increased angiogenic factor expression in PV mediated by the inflammation-related signaling. Conclusion: The angiogenic VEGF induction of IL-6 supports chronic inflammation that, through positive feedback, further promotes angiogenesis with concomitant JAK1/2 inhibition. |
format | Online Article Text |
id | pubmed-8268588 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-82685882021-07-10 VEGF Regulation of Angiogenic Factors via Inflammatory Signaling in Myeloproliferative Neoplasms Subotički, Tijana Mitrović Ajtić, Olivera Živković, Emilija Diklić, Miloš Đikić, Dragoslava Tošić, Milica Beleslin-Čokić, Bojana Dragojević, Teodora Gotić, Mirjana Santibanez, Juan F. Čokić, Vladan Int J Mol Sci Article Background: Chronic inflammation has been recognized in neoplastic disorders, including myeloproliferative neoplasm (MPN), as an important regulator of angiogenesis. Aims: We investigated the influence of vascular endothelial growth factor (VEGF) and pro-inflammatory interleukin-6 (IL-6) on the expression of angiogenic factors, as well as inflammation-related signaling in mononuclear cells (MNC) of patients with MPN and JAK2V617F positive human erythroleukemic (HEL) cells. Results: We found that IL-6 did not change the expression of angiogenic factors in the MNC of patients with MPN and HEL cells. However, IL-6 and the JAK1/2 inhibitor Ruxolitinib significantly increased angiogenic factors—endothelial nitric oxide synthase (eNOS), VEGF, and hypoxia-inducible factor-1 alpha (HIF-1α)—in patients with polycythemia vera (PV). Furthermore, VEGF significantly increased the expression of HIF-1α and eNOS genes, the latter inversely regulated by PI3K and mTOR signaling in the MNC of primary myelofibrosis (PMF). VEGF and inhibitors of inflammatory JAK1/2, PI3K, and mTOR signaling reduced the eNOS protein expression in HEL cells. VEGF also decreased the expression of eNOS and HIF-1α proteins in the MNC of PMF. In contrast, VEGF increased eNOS and HIF-1α protein expression in the MNC of patients with PV, which was mediated by the inflammatory signaling. VEGF increased the level of IL-6 immunopositive MNC of MPN. In summary, VEGF conversely regulated gene and protein expression of angiogenic factors in the MNC of PMF, while VEGF increased angiogenic factor expression in PV mediated by the inflammation-related signaling. Conclusion: The angiogenic VEGF induction of IL-6 supports chronic inflammation that, through positive feedback, further promotes angiogenesis with concomitant JAK1/2 inhibition. MDPI 2021-06-22 /pmc/articles/PMC8268588/ /pubmed/34206393 http://dx.doi.org/10.3390/ijms22136671 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Subotički, Tijana Mitrović Ajtić, Olivera Živković, Emilija Diklić, Miloš Đikić, Dragoslava Tošić, Milica Beleslin-Čokić, Bojana Dragojević, Teodora Gotić, Mirjana Santibanez, Juan F. Čokić, Vladan VEGF Regulation of Angiogenic Factors via Inflammatory Signaling in Myeloproliferative Neoplasms |
title | VEGF Regulation of Angiogenic Factors via Inflammatory Signaling in Myeloproliferative Neoplasms |
title_full | VEGF Regulation of Angiogenic Factors via Inflammatory Signaling in Myeloproliferative Neoplasms |
title_fullStr | VEGF Regulation of Angiogenic Factors via Inflammatory Signaling in Myeloproliferative Neoplasms |
title_full_unstemmed | VEGF Regulation of Angiogenic Factors via Inflammatory Signaling in Myeloproliferative Neoplasms |
title_short | VEGF Regulation of Angiogenic Factors via Inflammatory Signaling in Myeloproliferative Neoplasms |
title_sort | vegf regulation of angiogenic factors via inflammatory signaling in myeloproliferative neoplasms |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268588/ https://www.ncbi.nlm.nih.gov/pubmed/34206393 http://dx.doi.org/10.3390/ijms22136671 |
work_keys_str_mv | AT subotickitijana vegfregulationofangiogenicfactorsviainflammatorysignalinginmyeloproliferativeneoplasms AT mitrovicajticolivera vegfregulationofangiogenicfactorsviainflammatorysignalinginmyeloproliferativeneoplasms AT zivkovicemilija vegfregulationofangiogenicfactorsviainflammatorysignalinginmyeloproliferativeneoplasms AT diklicmilos vegfregulationofangiogenicfactorsviainflammatorysignalinginmyeloproliferativeneoplasms AT đikicdragoslava vegfregulationofangiogenicfactorsviainflammatorysignalinginmyeloproliferativeneoplasms AT tosicmilica vegfregulationofangiogenicfactorsviainflammatorysignalinginmyeloproliferativeneoplasms AT beleslincokicbojana vegfregulationofangiogenicfactorsviainflammatorysignalinginmyeloproliferativeneoplasms AT dragojevicteodora vegfregulationofangiogenicfactorsviainflammatorysignalinginmyeloproliferativeneoplasms AT goticmirjana vegfregulationofangiogenicfactorsviainflammatorysignalinginmyeloproliferativeneoplasms AT santibanezjuanf vegfregulationofangiogenicfactorsviainflammatorysignalinginmyeloproliferativeneoplasms AT cokicvladan vegfregulationofangiogenicfactorsviainflammatorysignalinginmyeloproliferativeneoplasms |